US EditionPublished • loading... • Updated
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
The selected abstract examines whether CBL-514 can improve weight-loss durability when paired with tirzepatide, a combination to be presented by W. Timothy Garvey, MD.
- On Thursday, Caliway Biopharmaceuticals announced that preclinical data for its CBL-514 drug candidate combined with GLP-1R-based therapies was selected for presentation at the American Diabetes Association's 2026 Scientific Sessions in New Orleans from June 5 to June 8.
- W. Timothy Garvey, Professor of Endocrinology and Obesity Medicine at the University of Alabama at Birmingham, will deliver the presentation, highlighting CBL-514's potential to improve weight-loss durability and adipose tissue remodeling when combined with GLP-1R therapies.
- CBL-514 is an injectable lipolysis drug inducing adipocyte apoptosis to reduce targeted fat areas. To date, 10 clinical trials involving 544 subjects have been completed with all efficacy and safety endpoints met.
- Caliway plans to engage face-to-face with global experts and multinational pharmaceutical companies during the meeting, aiming to deepen its global development strategy and expand into the obesity and metabolic medicine field.
- CEO Vivian Ling stated the selection "reflects continued recognition of the Company's research direction" in obesity and metabolism, underscoring Caliway's position as it enters a global market with more than 12,000 attending researchers and clinicians.
Insights by Ground AI
21 Articles
21 Articles
Waterloo Cedar Falls Courier+20 Reposted by 20 other sources
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
Preclinical research on Caliway's fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for presentation at the American Diabetes Association's 2026 Scientific Sessions.The presentation will be delivered by W. Timothy Garvey, MD, a globally recognized…
·Waterloo, United States
Read Full ArticleCoverage Details
Total News Sources21
Leaning Left1Leaning Right1Center13Last UpdatedBias Distribution87% Center
Bias Distribution
- 87% of the sources are Center
87% Center
C 87%
Factuality
To view factuality data please Upgrade to Premium
